Showing 97–101 of 101 results

Breast Tissue Markers Market Analysis | United States | 2016-2022 | MedCore

The value of the U.S. breast tissue marker market is expected to increase modestly over the forecast period. Growth in the value of the market will be driven by increasing unit sales and limited by ASP erosion. The increasing incidence of breast cancer and utilization of breast tissue markers in percutaneous breast biopsies as well as axillary lymph node marking are expected to fuel unit sales growth over the next seven years. ASP erosion will be driven by commoditization of breast tissue markers with lower clinical value.


Sacroiliac Joint Disorders and Fusion Market Analysis | United States | 2015-2021 | MedCore

Research findings included details on market sizing and trends, procedural data and competitive landscape, among other things. The research methodology and data collection for the analysis involved a multi-faceted approach which included: primary research, secondary research, utilization of iData’s proprietary in-house procedural database and an end-user physician online survey.


Emergency Room Equipment Market Report Suite | United States | 2011-2017 | MedSuite

The U.S. market for emergency room equipment includes patient monitoring, imaging, hi-tech, cardiac and vascular, and trauma equipment. Emergency rooms and departments are found in hospitals and some types of primary care centers, and provide treatment for a wide range of illnesses and injuries; many require the patient to be transferred to other treatment areas such as intensive care units, operating rooms, obstetric departments, imaging departments, long term care areas or quarantine areas. Patients who are admitted to emergency rooms enter the triage process, where the extent of their illness or injury is assessed so they can be transferred to the correct hospital department or treated immediately. In 2010, the average waiting time for a patient to be admitted to the emergency room was between just over two hours and almost five hours across the U.S.


Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite

The Asia-Pacific markets include Australia, China, Japan and South Korea. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, demineralized bone matrices and synthetics), hyaluronic acid (HA) viscosupplementation and bone morphogenetic protein (BMP) growth factor therapy. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest-growing segment in 2010, increasing almost 7% over the previous year.


Bone Graft Substitutes and Other Biomaterials Market Report Suite |Australia, Japan, South Korea | 2009-2015 | MedSuite

This study of the orthopedic biomaterials markets in Australia, Japan, South Korea and
China covers autograft, bone graft substitutes (allograft, DBM and synthetic), hyaluronic
acid viscosupplementation, and bone morphogenic growth factor therapy. In each country,
the different segments are analyzed by units, procedure numbers and average selling price.